PRRT2 and neoplasm: Although the detection of loss-of-function mutations in specific PKC isoforms has raised the possibility that some PKC family members may have tumor-suppressive functions (reviewed in [30]), it is likely that specific isoforms have pro- or anti-tumorigenic roles depending on the tumor tissue of origin and relative expression levels of these isoforms.